20/20 Biolabs(AIDX.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
20/20 Biolabs
AIDX.US
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S.
369.77 B
AIDX.USMarket value -Rank by Market Cap -/-

Financial Score

28/02/2026 Update
D
Health Care SuppliesIndustry
Industry Ranking41/45
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE0.00%D
    • Profit Margin-159.33%E
    • Gross Margin34.71%C
  • Growth ScoreB
    • Revenue YoY31.74%A
    • Net Profit YoY42.31%B
    • Total Assets YoY0.00%C
    • Net Assets YoY0.00%C
  • Cash ScoreC
    • Cash Flow Margin-62.76%D
    • OCF YoY31.74%A
  • Operating ScoreE
    • Turnover0E
  • Debt ScoreE
    • Gearing Ratio96.65%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    U.S. Stock Market Midday Update: 20/20 Biolabs' new product launch failed to boost confidence, with stock price plummeting 16.17%, raising market concerns

    Tracking Unusual Activity·
    US
    AIDX
    -6.37%
    Tracking Unusual Activity·
    US
    AIDX
    -6.37%

    Roth MKM Sticks to Their Buy Rating for HEALWELL AI (AIDX)

    Tip Ranks·
    US
    HAIAF
    0.00%
    US
    AIDX
    -6.37%
    Tip Ranks·
    US
    HAIAF
    0.00%
    US
    AIDX
    -6.37%

    12 Health Care Stocks Moving In Wednesday's Intraday Session

    benzinga_article·
    US
    BIB
    +1.74%
    US
    CDIOW
    +29.61%
    US
    IHE
    +1.22%
    benzinga_article·
    US
    BIB
    +1.74%
    US
    CDIOW
    +29.61%
    US
    IHE
    +1.22%

    U.S. stock market quick update: 20/20 Biolabs launched a new product but failed to boost its stock price, instead suffering a 28.20% plunge. Where is the market confidence?

    Tracking Unusual Activity·
    US
    AIDX
    -6.37%
    Tracking Unusual Activity·
    US
    AIDX
    -6.37%

    Pre-market hot trades in US stocks: 20/20 Biolabs up 10.53% pre-market; Mercadolibre down 4.29% pre-market

    Tracking Unusual Activity·
    US
    AIDX
    -6.37%
    US
    MELI
    +0.96%
    Tracking Unusual Activity·
    US
    AIDX
    -6.37%
    US
    MELI
    +0.96%
    © 2026 Longbridge｜Disclaimer